Attachment--and loss.

This report updates the 2009 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and control of influenza (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2009;58[No. RR-8] and CDC. Use of influenza A (H1N1) 2009 monovalent vaccine---recommendations of the Advisory Committee on Immunization Practices [ACIP], 2009. MMWR 2009;58:[No. RR-10]). The 2010 influenza recommendations include new and updated information. Highlights of the 2010 recommendations include 1) a recommendation that annual vaccination be administered to all persons aged >or=6 months for the 2010-11 influenza season; 2) a recommendation that children aged 6 months--8 years whose vaccination status is unknown or who have never received seasonal influenza vaccine before (or who received seasonal vaccine for the first time in 2009-10 but received only 1 dose in their first year of vaccination) as well as children who did not receive at least 1 dose of an influenza A (H1N1) 2009 monovalent vaccine regardless of previous influenza vaccine history should receive 2 doses of a 2010-11 seasonal influenza vaccine (minimum interval: 4 weeks) during the 2010--11 season; 3) a recommendation that vaccines containing the 2010-11 trivalent vaccine virus strains A/California/7/2009 (H1N1)-like (the same strain as was used for 2009 H1N1 monovalent vaccines), A/Perth/16/2009 (H3N2)-like, and B/Brisbane/60/2008-like antigens be used; 4) information about Fluzone High-Dose, a newly approved vaccine for persons aged >or=65 years; and 5) information about other standard-dose newly approved influenza vaccines and previously approved vaccines with expanded age indications. Vaccination efforts should begin as soon as the 2010-11 seasonal influenza vaccine is available and continue through the influenza season. These recommendations also include a summary of safety data for U.S.-licensed influenza vaccines. These recommendations and other information are available at CDC's influenza website (http://www.cdc.gov/flu); any updates or supplements that might be required during the 2010-11 influenza season also will be available at this website. Recommendations for influenza diagnosis and antiviral use will be published before the start of the 2010-11 influenza season. Vaccination and health-care providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information.

/pdf/prevention-and-control-of-seasonal-influenza-with-vaccines-4j4sn7f6zr.pdf

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

This activity will change the impact of competence and patient /client outcome by assisting hospital administrators, infection control practitioners, employee health clinicians, and HCP in Optimizing infection prevention and control programs. Diseasespecific outbreak control measures are described in this report. Nationwide, ongoing implementation of these vaccine recommendations through wellmanaged vaccination programs could substantially reduce both the number of susceptible HCP in any setting in which they interact with patients and their risks for transmitting vaccine-preventable diseases to other personnel and patients.

/pdf/immunization-of-health-care-personnel-recommendations-of-the-1j7f9oop6z.pdf

Immunization of health-care personnel: recommendations of the advisory committee on immunization practices (acip)

These clinical practice guidelines are an update of the guidelines published by the Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza pandemic. This document addresses new information regarding diagnostic testing, treatment and chemoprophylaxis with antiviral medications, and issues related to institutional outbreak management for seasonal influenza. It is intended for use by primary care clinicians, obstetricians, emergency medicine providers, hospitalists, laboratorians, and infectious disease specialists, as well as other clinicians managing patients with suspected or laboratory-confirmed influenza. The guidelines consider the care of children and adults, including special populations such as pregnant and postpartum women and immunocompromised patients.

/pdf/clinical-practice-guidelines-by-the-infectious-diseases-45uu7h3ko7.pdf

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

Influenza vaccination of health care workers in hospitals - a review of studies on attitudes and predictors.

OBJECTIVES: To evaluate the effect of staff influenza vaccination on all-cause mortality in nursing home residents. DESIGN: Pair-matched cluster-randomized trial. SETTING: Forty nursing homes matched for size, staff vaccination coverage during the previous season, and resident disability index. PARTICIPANTS: All persons aged 60 and older residing in the nursing homes. INTERVENTION: Influenza vaccine was administered to volunteer staff after a face-to-face interview. No intervention took place in control nursing homes. MEASUREMENTS: The primary endpoint was total mortality rate in residents from 2 weeks before to 2 weeks after the influenza epidemic in the community. Secondary endpoints were rates of hospitalization and influenza-like illness (ILI) in residents and sick leave from work in staff. RESULTS: Staff influenza vaccination rates were 69.9% in the vaccination arm versus 31.8% in the control arm. Primary unadjusted analysis did not show significantly lower mortality in residents in the vaccination arm (odds ratio 50.86, P 5.08), although multivariate-adjusted analysis showed 20% lower mortality (P 5.02), and a strong correlation was observed between staff vaccination coverage and all-cause mortality in residents (correlation coefficient 5 � 0.42, P 5.007). In the vaccination arm, significantly lower resident hospitalization rates were not observed, but ILI in residents was 31% lower (P 5.007), and sick leave from work in staff was 42% lower (P 5.03). CONCLUSION: These results support influenza vaccination of staff caring for institutionalized elderly people. JA m Geriatr Soc 57:1580‐1586, 2009.

/pdf/effect-of-influenza-vaccination-of-nursing-home-staff-on-3lrs4w3o5v.pdf

Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial.

Developing the Serious Games potential in nursing education

OBJECTIVES: To determine the risk factors (RFs) and the incidence of nosocomial pneumonia (NP).



DESIGN: Control/case study conducted from January 1 to April 15, 1999. Prospective enrollment.



SETTING: Geriatric university hospital with long-, intermediate-, and short-term care facilities.



PARTICIPANTS: Inpatients aged 65 and older with NP.



MEASUREMENTS: NP diagnosis relied on at least two clinical signs of respiratory infection and on chest radiography. Each NP case was randomly paired with two controls and followed up for 30 days to determine complication and mortality rates. RFs between cases and controls were compared (chi-square test, odds ratio (OR), 95% confidence interval, significance level P = .05). RFs that were significant in univariate analysis were tested using multivariate analysis and logistic regression.



RESULTS: Seventy-five cases of NP were diagnosed in 2,142 patients. The average incidence rate was 3.5% (short-term facilities = 0.5%; intermediate-term facilities = 8.3%; long-term care facilities = 5.3%). The complication rate was 58.1%. The most frequent complications were recurrent NP, heart and respiratory failure, phlebitis, and pressure ulcers. The NP mortality rate was 12.2%. The independent RFs of NP were a history of NP during the previous 6 months (OR = 4.50) and oxygen therapy (OR = 16.15), P < .001. Additional RFs were severe malnutrition, heart failure, prescription of antibiotics during the month preceding the emerging NP, eating dependency, and feeding by nasogastric tube.



CONCLUSION: The main RF for NP is a history of pneumonia. NP prevention in geriatrics should rely on early management of respiratory infections and malnutrition, surveillance of oxygen therapy and enteral feeding, rational use of antibiotics, and adaptation to the patient's dependency.

Risk factors for nosocomial pneumonia in a geriatric hospital: a control-case one-center study

Burden of infections among 44,869 elderly in nursing homes: a cross-sectional cluster nationwide survey.

Background: Annual immunization with influenza vaccine is effective in preventing influenza-associated mortality and morbidity in the elderly. Pneumococcal vaccination is also consi

Monique Rothan-Tondeur

Papers

Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial.

Developing the Serious Games potential in nursing education

Risk factors for nosocomial pneumonia in a geriatric hospital: a control-case one-center study

Burden of infections among 44,869 elderly in nursing homes: a cross-sectional cluster nationwide survey.

Influenza and Pneumococcal Vaccine Coverages in Geriatric Health Care Settings in France